Symbiomix Therapeutics is a biopharmaceutical company bringing innovative medicines to market for prevalent gynecological infections than can have serious health consequences. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world’s leading healthcare venture capital firms: OrbiMed, F-Prime Capital Partners, and HBM Partners. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.
Medically Reviewed
ADVERTISEMENT
Contraception Is Free to Women, Except When It’s Not
Despite the ACA's guarantees of free contraception coverage, obtaining the right product at no cost can be onerous
23 Jul 2021
Sexual Health
Should Fully Immunized People Wear Masks Indoors? An Infectious Disease Physician Weighs In
Whether or not the fully vaccinated need to wear masks inside largely depends on where they live and hospitalization rates
22 Jul 2021
Your Health
